Smartphone App and CO Self-monitoring for Smoking Cessation

HIV Clinical Trial

— SMART-CO  

Official title:

Support by Smartphone App and Carbon Monoxide Self-monitoring for Smoking Cessation: a Randomised Controlled Trial Nested Into the Swiss HIV Cohort Study

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02840513
• Other study ID #: AN1
• Status: Terminated
• Phase: Phase 4
• Start date: June 1, 2017
• Est. completion date: June 24, 2019

Study information

• Verified date: July 2020
• Source: Basel Institute for Clinical Epidemiology and Biostatistics
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This randomized controlled trial is going to evaluate whether an intervention consisting of a smartphone application to assist smokers living with HIV to quit in combination with CO self-monitoring compared to stop smoking counselling by physicians during usual care results in higher self-reported and biochemically verified smoking cessation rates at 6 months.

.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 81
• Est. completion date: June 24, 2019
• Est. primary completion date: June 24, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

HIV-infected smokers = 16 years and smoking = 3 cigarettes /day enrolled into the Swiss HIV Cohort Study Willingness to quit smoking Speaking one or more of offical Swiss national languages or English Users of smartphone (specifically iPhone 5, 5c, 5s, 6, 6+ running iOS Version 8.0+; smartphones with resolution of at least 800x400 pixels running, Android Version 5.0+, and Android smartwatches) Informed consent

Exclusion Criteria:

Limitations in hearing, comprehension or vision problems that preclude full study participation Participants with a life expectancy of less than 12 months due to any serious medical condition

Related Conditions & MeSH terms

• HIV
• Smoking

Intervention

Other:
• Smartphone app/CO self-monitoring
Smartphone app and carbon monoxide self-monitoring (personal device)

Locations

Country	Name	City	State
Switzerland	University Hospital of Basel	Basel

Sponsors (1)

Lead Sponsor	Collaborator
Alain Nordmann

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Self-reported abstinence biochemically verified by a carbon monoxide test in-person		6 months
Secondary	Differences in the number of daily cigarettes smoked from baseline to 6-month follow-up and point prevalence of abstinence (ie, no smoking in the past 7 days) at 6-month follow-up.		6 months